Get started
Author

Xiaobo Zhong

Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
2017 · Paolo A. Muraro, Marcelo Pasquini, et al. · JAMA Neurology · 275
Hematopoietic Cell Transplant Comorbidity Index Is Predictive of Survival after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma
2013 · Ayman Saad, Anuj Mahindra, et al. · Transplantation and Cellular Therapy · 121
PDF
Trends in Utilization and Outcomes of Autologous Transplantation as Early Therapy for Multiple Myeloma
2013 · Luciano J. Costa, Mei-Jie Zhang, et al. · Transplantation and Cellular Therapy · 111
PDF
Salvage Second Hematopoietic Cell Transplantation in Myeloma
2013 · Laura C. Michaelis, Ayman Saad, et al. · Transplantation and Cellular Therapy · 108
PDF
Lenalidomide Maintenance for High-Risk Multiple Myeloma after Allogeneic Hematopoietic Cell Transplantation
2014 · Melissa Alsina, Pamela S. Becker, et al. · Transplantation and Cellular Therapy · 98
PDF
Alternative Donor Transplantation for Older Patients with Acute Myeloid Leukemia in First Complete Remission: A Center for International Blood and Marrow Transplant Research-Eurocord Analysis
2014 · Daniel Weisdorf, Mary Eapen, et al. · Transplantation and Cellular Therapy · 88
PDF
Older Patients with Myeloma Derive Similar Benefit from Autologous Transplantation
2014 · Manish Sharma, Mei-Jie Zhang, et al. · Transplantation and Cellular Therapy · 83
PDF
Ide-cel vs standard regimens in triple-class–exposed relapsed and refractory multiple myeloma: updated KarMMa-3 analyses
2024 · Sikander Ailawadhi, Bertrand Arnulf, et al. · Blood · 78
Nonadherence to Medications for Chronic Conditions and Nonadherence to Adjuvant Hormonal Therapy in Women With Breast Cancer
2016 · Alfred I. Neugut, Xiaobo Zhong, et al. · JAMA Oncology · 76
Lymphovascular invasion is an independent predictor of survival in breast cancer after neoadjuvant chemotherapy
2016 · Ying L. Liu, Anurag Saraf, et al. · Breast Cancer Research and Treatment · 72
Impact of Pretransplant Therapy and Depth of Disease Response before Autologous Transplantation for Multiple Myeloma
2014 · Ravi Vij, Shaji Kumar, et al. · Transplantation and Cellular Therapy · 72
PDF
Transplantation for Autoimmune Diseases in North and South America: A Report of the Center for International Blood and Marrow Transplant Research
2012 · Marcelo C. Pasquini, Julio Voltarelli, et al. · Transplantation and Cellular Therapy · 71
PDF
Does androgen deprivation therapy protect against severe complications from COVID-19?
2020 · V.G. Patel, X. Zhong, et al. · Annals of Oncology · 69
PDF
Psychosocial factors related to non-persistence with adjuvant endocrine therapy among women with breast cancer: the Breast Cancer Quality of Care Study (BQUAL)
2016 · Dawn L. Hershman, Lawrence H. Kushi, et al. · Breast Cancer Research and Treatment · 62
Second transplants for multiple myeloma relapsing after a previous autotransplant—reduced-intensity allogeneic vs autologous transplantation
2013 · C O Freytes, D H Vesole, et al. · Bone Marrow Transplantation · 57
Bone Marrow or Peripheral Blood for Reduced-Intensity Conditioning Unrelated Donor Transplantation
2014 · Mary Eapen, Brent R. Logan, et al. · Journal of Clinical Oncology · 56
New Cancers after Autotransplantations for Multiple Myeloma
2014 · Anuj Mahindra, Girindra Raval, et al. · Transplantation and Cellular Therapy · 47
PDF
ReCAP: Identifying Severe Adverse Event Clusters Using the National Cancer Institute’s Common Terminology Criteria for Adverse Events
2016 · Xiaobo Zhong, Emerson A. Lim, et al. · Journal of Oncology Practice · 40
Effect of Postremission Therapy before Reduced-Intensity Conditioning Allogeneic Transplantation for Acute Myeloid Leukemia in First Complete Remission
2013 · Erica D. Warlick, Kristjan Paulson, et al. · Transplantation and Cellular Therapy · 34
PDF
Bortezomib-based induction for transplant ineligible AL amyloidosis and feasibility of later transplantation
2015 · R F Cornell, X Zhong, et al. · Bone Marrow Transplantation · 30
Effect of concurrent beta-blocker use in patients receiving immune checkpoint inhibitors for advanced solid tumors
2022 · George Mellgard, Vaibhav G. Patel, et al. · Journal of Cancer Research and Clinical Oncology · 28
PDF
Pre-surgical trial of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer: a New York Cancer Consortium trial
2018 · K. Kalinsky, J. A. Sparano, et al. · Clinical & Translational Oncology · 28
HLA polymorphism and risk of multiple myeloma
2016 · M Beksac, L Gragert, et al. · Leukemia · 28
Comorbidity and Sociodemographic determinants in COVID-19 Mortality in an US Urban Healthcare System
2020 · An-Li Wang, Xiaobo Zhong, et al. · medRxiv · 25
PDF
Using the Taxonomy: A Standard Vocabulary of Chaplain Activities
2019 · Vanshdeep Sharma, Deborah B. Marin, et al. · Journal of Health Care Chaplaincy · 24
Works count: 91
Citation count: 2,152
H-index: 25
I10-index: 41
Year
Topic
Type